z-logo
open-access-imgOpen Access
Bacterial Factors That Predict Relapse after Tuberculosis Therapy
Author(s) -
Roberto Colangeli,
Hannah Jedrey,
Soyeon Kim,
Roy Connell,
Shuyi Ma,
Uma Deepthi Chippada Venkata,
Soumitesh Chakravorty,
Aditi Gupta,
Erin Sizemore,
Lois Diem,
David R. Sherman,
Alphonse Okwera,
Reynaldo Dietze,
W. Henry Boom,
John L. Johnson,
William R. Mac Kenzie,
David Alland
Publication year - 2018
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1715849
Subject(s) - tuberculosis , medicine , intensive care medicine , pathology
Approximately 5% of patients with drug-susceptible tuberculosis have a relapse after 6 months of first-line therapy, as do approximately 20% of patients after 4 months of short-course therapy. We postulated that by analyzing pretreatment isolates of Mycobacterium tuberculosis obtained from patients who subsequently had a relapse or were cured, we could determine any correlations between the minimum inhibitory concentration (MIC) of a drug below the standard resistance breakpoint and the relapse risk after treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom